# OnCo record create-medicines (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/create-medicines/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "create-medicines" ;
  schema:name "CREATE Medicines"@en ;
  schema:alternateName "CREATE Medicines, Inc."@en, "Myeloid Therapeutics"@en, "Myeloid Therapeutics, Inc."@en ;
  schema:description "CREATE Medicines, formerly Myeloid Therapeutics, uses messenger RNA in fat particles, given by drip, to teach a patient's own immune cells inside the body to attack cancer, without collecting and engineering cells in a laboratory. Its cancer trials are in liver, stomach and oesophageal cancers and other solid tumours."@en ;
  schema:url <https://onco.cc/companies/create-medicines/>, <https://createmedicines.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://createmedicines.com/>, <https://www.biospace.com/press-releases/create-medicines-and-amsterdam-university-medical-center-initiate-first-in-vivo-car-therapy-trial-in-frontline-setting-for-solid-tumors>, <https://www.biospace.com/press-releases/create-medicines-doses-first-patient-in-frontline-hcc-trial-evaluating-mt-303-an-in-vivo-car-therapy-in-combination-with-standard-of-care-immunotherapy>, <https://createmedicines.com/news/create-medicines-expands-clinical-in-vivo-car-pipeline-and-lnp-technology-suite-by-forming>, <https://clinicaltrials.gov/study/NCT06478693>, <https://web.archive.org/web/20261016142320/https://www.archventure.com/portfolio/> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/gastric/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/>, <https://onco.cc/fronts/cell-therapy/> ;
  onco:technologies <https://onco.cc/technologies/in-vivo-car-t/>, <https://onco.cc/technologies/car-nk-macrophage/> ;
  onco:targets <https://onco.cc/targets/trop2/>, <https://onco.cc/targets/gpc3/>, <https://onco.cc/targets/her2/> ;
  onco:drugs <https://onco.cc/drugs/mt-302/>, <https://onco.cc/drugs/mt-303/>, <https://onco.cc/drugs/mt-304/> ;
  onco:trials <https://onco.cc/trials/nct05969041/> .